NCT04504955

CorEvitas Atopic Dermatitis Registry: A Study of Post Approval Drug Safety and Effectiveness

• Status: Enrolling By Invitation
• Phase: —
• Study type: Observational
• Enrollment: 10,000 (estimated)
• Sponsor: CorEvitas · Network
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This prospective, non-interventional research registry is designed to study the comparative effectiveness and comparative safety of approved treatments for patients with atopic dermatitis under the care of a licensed dermatologist or qualified physician extender. Secondary objectives include analyzing the epidemiology and natural history of the disease, its comorbidities, and current treatment practices. Condition or disease : Atopic Dermatitis

Detailed description

The objective of the CorEvitas Atopic Dermatitis (AD) Registry is to create a national cohort of patients with atopic dermatitis. Data collected will be used to extensively evaluate the effectiveness and safety of medications used to treat atopic dermatitis. This will be done through the standardized collection of patient-reported outcomes (PRO) and clinician-reported outcomes (ClinRO), and the prevalence and incidence of comorbidities and adverse events, medication utilization patterns, and patient productivity measures.

Conditions

• Atopic Dermatitis

Interventions

Type	Name	Description
OTHER	Observational Non-Interventional Registry	Observational Non-Interventional Registry

Timeline

• Start date: 2020-07-14
• Primary completion: 2100-12-01
• Completion: 2100-12-01
• First posted: 2020-08-07
• Last updated: 2026-02-09

Locations

1 site across 1 country: United States